Tag: Kanvas Biosciences

Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients

Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients

The investment round, which includes Gates Foundation, will advance Kanvas’ lead immuno-oncology drug that seeks to improve the efficacy of immunotherapy in the treatment of solid organ cancers. PRINCETON, N.J.–(BUSINESS WIRE)–Kanvas Biosciences, a full-stack spatial…

Read More Read More

Kanvas Biosciences has filed a notice of an exempt offering of securities to raise $10 Million in New Equity Investment.

Kanvas Biosciences has filed a notice of an exempt offering of securities to raise $10 Million in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Kanvas Biosciences is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Matthew Cheng played a…

Read More Read More